Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms

• Mengshi Hu,
• Tao Yang,
• Linyu Yang,
• Lu Niu,
• Jinbing Zhu,
• Ailin Zhao,
• Mingsong Shi,
• Xue Yuan,
• Minghai Tang,
• Jianhong Yang,
• Heying Pei,
• Zhuang Yang,
• Qiang Chen,
• Haoyu Ye,
• Ting Niu,
• Lijuan Chen

Affiliations

Mengshi Hu

State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University

Tao Yang

State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University

Linyu Yang

State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University

Lu Niu

State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University

Jinbing Zhu

Department of Hematology and Research Laboratory of Hematology, West China Hospital of Sichuan University

Ailin Zhao

Department of Hematology and Research Laboratory of Hematology, West China Hospital of Sichuan University

Mingsong Shi

State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University

Xue Yuan

State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University

Minghai Tang

State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University

Jianhong Yang

State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University

Heying Pei

State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University

Zhuang Yang

State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University

Qiang Chen

State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University

Haoyu Ye

State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University

Ting Niu

State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University

Lijuan Chen

State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University